Clinical trial
A Phase II Study of Oxaliplatin in Children With Recurrent Solid Tumors
NCT00091182 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Oxaliplatin in Children With Recurrent Solid Tumors
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- Not reported
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
childhood central nervous system germ cell tumor, childhood extragonadal germ cell tumor, childhood hepatoblastoma, childhood hepatocellular carcinoma, childhood high-grade cerebral astrocytoma, childhood low-grade cerebral astrocytoma, childhood malignant ovarian germ cell tumor, childhood malignant testicular germ cell tumor, childhood teratoma, recurrent adrenocortical carcinoma, recurrent childhood brain stem glioma, recurrent childhood cerebellar astrocytoma, recurrent childhood cerebral astrocytoma, recurrent childhood ependymoma, recurrent childhood liver cancer, recurrent childhood malignant germ cell tumor, recurrent childhood rhabdomyosarcoma, recurrent childhood soft tissue sarcoma, recurrent childhood visual pathway and hypothalamic glioma, recurrent colon cancer, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent nasopharyngeal cancer, recurrent neuroblastoma, recurrent osteosarcoma, recurrent rectal cancer, recurrent renal cell cancer